TOLEROGENER DNA-IMPFSTOFF

Patent europeic · EP3534936 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3534936
Numer da la dumonda
EP17801363
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
01-11-2017
Publitgà
11-09-2019
Concedì
21-10-2020
La protecziun finescha il pli tard
31-10-2037
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
A61K 39/00 (2006.01)
A61P 3/10 (2006.01)
Prioritad
US 201662415717 P 01.11.2016
EP 17150037 02.01.2017
EP 17169019 02.05.2017
EP 17177289 22.06.2017
EP 17198041 24.10.2017
Dumonda PCT
PCT/EP2017/077949 01.11.2017
Publicaziun PCT
WO2018/083111 11.05.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-12-2025

    Midada

    Published in Swissreg on 01.12.2025

  2. 01-12-2024

    Midada

    Published in Swissreg on 01.12.2024

  3. 01-12-2023

    Midada

    Published in Swissreg on 01.12.2023

  4. 01-12-2022

    Midada

    Published in Swissreg on 01.12.2022

  5. 21-10-2020

    Concedì

    Published in Swissreg on 21.10.2020

Partidas

Possessur

Novo Nordisk A/S

Novo Allé, 2880 Bagsværd, DK

Inventur

CHAPLIN, Jay

2880 Bagsværd, DK

WIJARANAKULA, Michael

2880 Bagsværd, DK

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.